Protein Supplementation After ACL Surgery

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age16-40
SponsorThe Methodist Hospital Research Institute

About this trial

The purpose of the study is to assess the longitudinal post-operative care effects of protein supplementation on muscle atrophy in the post-operative period following ACL reconstruction. The main outcome will be muscle size/mass as measured using dual energy x-ray absorptiometry (DEXA) scanning. The primary objective is to assess for any beneficial impact of protein supplementation, with implications of standardizing a recommended protocol for protein supplementation after ACL reconstruction.

Secondary outcomes will be to evaluate the survey data from the KOOS JR and Tampa Scale surveys, as well as functional measures recorded during physical therapy.

Eligibility criteria

Qualifiers

Subjects will include patients age 16 to 40 undergoing primary ACL reconstruction for an acute ACL tear with the PI or Sub-investigators

Disqualifiers

Subjects will not be included if they meet one of the following criteria

History of meniscectomy or meniscus repair

Obesity (BMI>35)

Diabetes

Trial design

Treatments tested in this trial

  • Whey protein isolate
  • Protein + BAA
  • Placebo

Treatment groups

102 Participants
are divided into 3 treatment groups